- HOME
- Rinsho Shinkeigaku (Clinical Neurology)
- Vol.52 No.11
Vol.52 No.11 contents
Presidential Address
Roles of cerebrovascular innervations and their neurotransmitters in various pathological conditions of central nervous system
Norihiro Suzuki, M.D., Ph.D.
CLINICA NEUROL, 52: 819|824, 2012
Opening Seminar 1
The Clinical Definition of Parkinson's Disease -Time for a Change?
Werner Poewe, M.D.
CLINICA NEUROL, 52: 825|825, 2012
Opening Seminar 2
Ischemic Stroke and the Fate of Cerebral Microvessels
Gregory J. del Zoppo, M.D.
CLINICA NEUROL, 52: 826|826, 2012
Educational Lecture 1
Involuntary movements: Video presentation
Yoshikazu Ugawa, M.D.
CLINICA NEUROL, 52: 827|831, 2012
Educational Lecture 1
Recent clinical trials on treatment of myasthenia gravis
Hiroaki Yoshikawa
CLINICA NEUROL, 52: 832|835, 2012
Educational Lecture 1
Diagnostic and therapeutic scheme of autoimmune mediated encephalitis/encephalopathy
Yukitoshi Takahashi, M.D.
CLINICA NEUROL, 52: 836|839, 2012
Educational Lecture 1
Surgical therapy for entrapment neuropathy
Shigekuni Tachibana, M.D.
CLINICA NEUROL, 52: 840|843, 2012
Educational Lecture 1
Clinical genetics of amyotrophic lateral sclerosis in Japan: an update
Masashi Aoki, M.D., Hitoshi Warita, M.D., Naoki Suzuki, M.D. and Masaaki Kato, M.D.
CLINICA NEUROL, 52: 844|847, 2012
Educational Lecture 1
Correlation between EEG and neuroimaging
Shozo Tobimatsu, M.D., Ph. D.
CLINICA NEUROL, 52: 848|850, 2012
Educational Lecture 1
Neuropathology of mild cognitive impairment
Masaki Takao, M.D.
CLINICA NEUROL, 52: 851|854, 2012
Educational Lecture 1
Faculty development for neurology education
Masanaga Yamawaki
CLINICA NEUROL, 52: 855|856, 2012
Educational Lecture 2
Diagnostic approach for studying epileptic seizure
Keiko Usui, M.D., Ph.D., Kiyohito Terada, M.D., Ph.D. and Yushi Inoue, M.D., Ph.D.
CLINICA NEUROL, 52: 857|860, 2012
Educational Lecture 2
Pathophysiological regulation of cellular stress response by Keap1-Nrf2 system
Masayuki Yamamoto, M.D., Ph.D.
CLINICA NEUROL, 52: 861|861, 2012
Educational Lecture 2
Sensory input and basal ganglia
Yoshikazu Ugawa, M.D.
CLINICA NEUROL, 52: 862|865, 2012
Educational Lecture 2
Psychosomatic approach for chronic headache
Masahiro Hashizume
CLINICA NEUROL, 52: 866|868, 2012
Educational Lecture 2
Clinical points for progressive muscular dystrophy-Is immobobilization the only concernH-
Hirofumi Komaki, M.D.
CLINICA NEUROL, 52: 869|873, 2012
Educational Lecture 2
Keywords for study of pathological conditions of neurodegenerative diseases
Yoshitaka Nagai, M.D., Ph.D.
CLINICA NEUROL, 52: 874|876, 2012
Educational Lecture 2
Series of clinical ethics necessary for neurological medicine
-"Bad news telling" with a focus on notification of intractable diseases
Mieko Ogino
CLINICA NEUROL, 52: 877|877, 2012
Educational Lecture 2
Neuroimmunological diseases and pregnancy
Yuko Shimizu, M.D., Ph.D.
CLINICA NEUROL, 52: 878|881, 2012
Educational Lecture 3
Current state of recanalization therapy in acute ischemic stroke
Haruhiko Hoshino, M.D.
CLINICA NEUROL, 52: 882|884, 2012
Educational Lecture 3
Recent trend in subacute meningitides
Satoshi Kamei, M.D.
CLINICA NEUROL, 52: 885|888, 2012
Educational Lecture 3
Neurogenetics useful in clinical practice (with a focus on spinocerebellar degeneration)
Yuji Takahashi
CLINICA NEUROL, 52: 889|889, 2012
AAN-JSN Joint Symposium (2)
Medical Therapy for Parkinson's Disease
-the Current State of the Art
C. Warren Olanow, M.D.
CLINICA NEUROL, 52: 890|890, 2012
AAN-JSN Joint Symposium (2)
The Transition of Deep Brain Stimulation from Disease Specific to Symptom Specific Indications
Michael S. Okun, M.D.
CLINICA NEUROL, 52: 891|895, 2012
AAN-JSN Joint Symposium (2)
Gene therapy for Parkinson's disease
Shin-ichi Muramatsu, M.D.
CLINICA NEUROL, 52: 896|898, 2012
AAN-JSN Joint Symposium (2)
Investigation of Pathophysiology of Parkinson's Disease Using iPS Cells Technology
Hideyuki Okano, M.D.
CLINICA NEUROL, 52: 899|899, 2012
AAN-JSN Joint Symposium (2)
Novel Migraine Mechanisms as Targets for Therapy
Andrew Charles, M.D.
CLINICA NEUROL, 52: 900|900, 2012
AAN-JSN Joint Symposium (2)
Migraine Diagnosis: Screening Items, Instruments and Scales
Shuu-Jiun Wang, M.D.
CLINICA NEUROL, 52: 901|901, 2012
AAN-JSN Joint Symposium (2)
Episodic to Chronic Migraine: The Basis for the Transformation
David W. Dodick, M.D.
CLINICA NEUROL, 52: 902|902, 2012
AAN-JSN Joint Symposium (2)
Refractory Migraine: Mechanisms and Management
Yasuo Terayama, M.D.
CLINICA NEUROL, 52: 903|903, 2012
Symposium 1
CREB activation is a key player for ischemic tolerance in the brain
Kazuo Kitagawa, M.D., Tsutomu Sasaki, M.D., Yasukazu Terasaki, M.D., Yoshiki Yagita, M.D. and Hideki Mochizuki, M.D.
CLINICA NEUROL, 52: 904|907, 2012
Symposium 1
Molecular mechanism and new protective strategy for ischemic white matter damages
Takao Urabe, M.D., Ph.D.
CLINICA NEUROL, 52: 908|910, 2012
Symposium 1
Novel neuroprotective agents: a HIF activator and an Akt activator
Shunya Takizawa1), Eiichiro Nagata1) and Hongbo R. Luo2)
CLINICA NEUROL, 52: 911|912, 2012
Symposium 1
Biphasic Inflammatory Responses in Injury and Repair after Stroke
Eng H. Lo, M.D.
CLINICA NEUROL, 52: 913|913, 2012
Symposium 1
Guillain-Barré and Fisher syndromes: update on the pathophysiological role of antiganglioside antibodies
Kenichi Kaida, M.D.
CLINICA NEUROL, 52: 914|916, 2012
Symposium 1
Recent topics of chronic inflammatory demyelinating polyneuropathy
Masahiro Iijima
CLINICA NEUROL, 52: 917|919, 2012
Symposium 1
Multifocal motor neuropathy: Current review of epidemiology and treatment
Naoko Matsui, M.D.
CLINICA NEUROL, 52: 920|922, 2012
Symposium 1
Treatment for POEMS syndrome: The current status and tasks for the future
Sonoko Misawa, M.D.
CLINICA NEUROL, 52: 923|924, 2012
Symposium 1
Ideal subspecialty training in the field of neurology\Competence required for the experts: Neurophysiology
Nobuo Kohara, M.D.
CLINICA NEUROL, 52: 925|926, 2012
Symposium 1
Competence required for neuroimaging abilities in neurologists
Hidenao Fukuyama, M.D., Ph.D.
CLINICA NEUROL, 52: 927|930, 2012
Symposium 1
Practical approach to neuropathology required for experts
Mari Yoshida, M.D., Ph.D.
CLINICA NEUROL, 52: 931|932, 2012
Symposium 1
Subspeciality Training for Neurologists-Neurogenetics
Tatsushi Toda
CLINICA NEUROL, 52: 933|933, 2012
Symposium 1
The fate of injured motor neurons and the behavior of surrounding glial cells
Hiroshi Kiyama, Ph.D.
CLINICA NEUROL, 52: 934|936, 2012
Symposium 1
Exploring the neural diseases using stem cell technology
Wado Akamatsu
CLINICA NEUROL, 52: 937|938, 2012
Symposium 1
Regenerating neurons by using endogenous neuronal progenitor cells
Kazunobu Sawamoto, Ph.D.
CLINICA NEUROL, 52: 939|941, 2012
Symposium 1
Therapeutic role of regenerative factor "HGF" in ALS and other neurodegenerative disorders
Hiroshi Funakoshi1) and Toshikazu Nakamura2)
CLINICA NEUROL, 52: 942|942, 2012
Symposium 1
Iron metabolism in the central nervous system
Kunihiro Yoshida, M.D.
CLINICA NEUROL, 52: 943|946, 2012
Symposium 1
Clinical features of superficial siderosis
Takemori Yamawaki, M.D., Ph.D.
CLINICA NEUROL, 52: 947|950, 2012
Symposium 1
Clinical feature of neuroferritinopathy
Emiko Ohta
CLINICA NEUROL, 52: 951|954, 2012
Symposium 1
Imaging of diseases with iron deposition
Suketaka Momoshima, M.D.
CLINICA NEUROL, 52: 955|958, 2012
Symposium 1
Neuropathology of superficial hemosiderosis and neuroferritinopathy
Masaki Takao, M.D.
CLINICA NEUROL, 52: 959|961, 2012
Symposium 1
Prevalence of dementia in Japan: past, present and future
Takashi Asada, M.D.
CLINICA NEUROL, 52: 962|964, 2012
Symposium 1
Depression, motor function and cognitive function in epidemiological study
Kenji Wada, M.D. and Kenji Nakashima, M.D.
CLINICA NEUROL, 52: 965|967, 2012
Symposium 1
Non-genetic risk factors for dementia
Naoyuki Sato, M.D.
CLINICA NEUROL, 52: 968|970, 2012
Symposium 1
Triptans and Calcitonin gene-related peptide (CGRP) receptor antagonists
Kiyoshi Negoro, M.D., Ph.D.
CLINICA NEUROL, 52: 971|972, 2012
Symposium 1
Drugs for migraine prophylaxis
Takao Takeshima, M.D., Ph.D.
CLINICA NEUROL, 52: 973|975, 2012
Symposium 1
Treatment of chronic migraine and medication overuse headache
Junichi Hamada, M.D.
CLINICA NEUROL, 52: 976|977, 2012
Symposium 1
Anti-NMDA receptor encephalitis: Pathogenic mechanisms and treatment algorithm
Josep Dalmau, M.D.
CLINICA NEUROL, 52: 978|978, 2012
Symposium 1
Associated tumors in patients with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis
Makoto Hara, M.D., Akihiko Morita, M.D. and Satoshi Kamei, M.D.
CLINICA NEUROL, 52: 979|981, 2012
Symposium 1
Localization of NMDAR-related epitopes in ovarian teratoma: comparison between patients and controls
Naoko Tachibana, M.D.1)and Shu-ichi Ikeda, M.D.2)
CLINICA NEUROL, 52: 982|984, 2012
Symposium 1
Clinical profiles of Japanese patients with anti-NMDAR encephalitis and functional analysis of the anti-NMDAR antibodies
Keiko Tanaka, M.D.
CLINICA NEUROL, 52: 985|987, 2012
Symposium 1
What is ataxia?-Towards developing a new scale for ataxia
Osamu Onodera, M.D.
CLINICA NEUROL, 52: 988|989, 2012
Symposium 1
Cerebellar internal clock: its neural mechanisms and functional roles
Tadashi Yamazaki
CLINICA NEUROL, 52: 990|993, 2012
Symposium 1
Memory transfer in cerebellar motor learning
Soichi Nagao
CLINICA NEUROL, 52: 994|996, 2012
Symposium 1
Ataxic dysarthria
Yukiko Ikui
CLINICA NEUROL, 52: 997|1000, 2012
Symposium 1
Cerebellum and eye movement control
-Neuronal mechanisms of memory-based smooth-pursuit and their early clinical application-
Kikuro Fukushima1), Junko Fukushima2), Norie Ito3), Hidetoshi Takei4), Kunihiro Ikeno4), Peter M Olley1), Susumu Chiba3), Nobuyoshi Kobayashi3), Kiyoharu Inoue3) and Tateo Warabi1)3)
CLINICA NEUROL, 52: 1001|1005, 2012
Symposium 1
Cortical spreading depression and molecular genetics in migraine
Hisanori Kowa, M.D., Ph.D. and Kenji Nakashima, M.D., Ph.D.
CLINICA NEUROL, 52: 1006|1008, 2012
Symposium 1
Monitoring cerebral blood volume changes during migraine attack by using near-infrared spectroscopy
Yuka Watanabe, M.D., Ph.D., Hideaki Tanaka, M.D., Ph.D., Ryotaro Takashima, M.D., Ph.D., Masatsugu Takano, M.D., Kazuhito Kimoto, M.D. and Koichi Hirata, M.D., Ph.D.
CLINICA NEUROL, 52: 1009|1011, 2012
Symposium 1
Mechanisms underlying migraine chronification
Mamoru Shibata
CLINICA NEUROL, 52: 1012|1013, 2012
Symposium 1
Identification of biomarkers associated with migraine
Eiichiro Nagata, M.D.
CLINICA NEUROL, 52: 1014|1017, 2012
Symposium 1
Misregulation of alternative splicing and microRNA processing in DM1 pathogenesis
Denis Furling, Ph.D.
CLINICA NEUROL, 52: 1018|1022, 2012
Symposium 1
Repeat-Associated Diseases, Mutagenesis, Pathogenesis, and Therapeutic Avenues
Christopher E. Pearson, M.D.
CLINICA NEUROL, 52: 1023|1023, 2012
Symposium 1
What is professionalism?
Sadayoshi Ohbu, M.D. MMedSc (Clin. Epid), F.A.C.P.
CLINICA NEUROL, 52: 1024|1026, 2012
Symposium 1
Professionalism and the Japanese Society of Neurology-For the next 100 years-
Hidehiro Mizusawa, M.D., Ph.D.
CLINICA NEUROL, 52: 1028|1030, 2012
Symposium 1
Perspective of graduate medical education in the Japanese Society of Neurology
Masatoyo Nishizawa, M.D.
CLINICA NEUROL, 52: 1031|1032, 2012
Symposium 1
Epilepsy and law
Masato Matsuura
CLINICA NEUROL, 52: 1033|1035, 2012
Symposium 1
Building epilepsy care network in Japan
Taisuke Otsuki, M.D., Ph.D.
CLINICA NEUROL, 52: 1036|1038, 2012
Symposium 1
Long-term perspectives of epilepsy treatment and care
Yushi Inoue, M.D.
CLINICA NEUROL, 52: 1039|1042, 2012
Symposium 2
The MG-QOL15 Japanese version: validation and associations with clinical factors
Masayuki Masuda, M.D.1), Kimiaki Utsugisawa, M.D.2), Shigeaki Suzuki, M.D.3), Yuriko Nagane, M.D.2), Suguru Ito, M.D.1), Chiaki Kabasawa, M.D.4), Yasushi Suzuki, M.D.5), Yuko Shimizu, M.D.4), Hiroya Utsumi, M.D.1), Kazuo Fujihara, M.D.6), Shinichiro Uchiyama, M.D.4) and Norihiro Suzuki, M.D.3)
CLINICA NEUROL, 52: 1043|1046, 2012
Symposium 2
Directions for use of corticosteroids and calcineurin inhibitors against generalized myasthenia gravis: therapeutic strategies that can lead to early improvements and veer away from high-dose oral corticosteroids
Kimiaki Utsugisawa, M.D.1), Yuriko Nagane, M.D.1), Shigeaki Suzuki, M.D.2) and Norihiro Suzuki, M.D.2)
CLINICA NEUROL, 52: 1047|1050, 2012
Symposium 2
Plasmapheresis and immunoglobulin therapy
Hidenori Matsuo
CLINICA NEUROL, 52: 1051|1052, 2012
Symposium 2
Indication of extended thymectomy in patients with myasthenia gravis
Hiroaki Yoshikawa
CLINICA NEUROL, 52: 1053|1055, 2012
Symposium 2
Intracellular seeded aggregation of TDP-43
Takashi Nonaka and Masato Hasegawa
CLINICA NEUROL, 52: 1056|1058, 2012
Symposium 2
Whether or not ALS lesions spread contiguously?
Tadashi Kanouchi1), Teruhiko Sekiguchi2), Hidehiro Mizusawa2) and Takanori Yokota2)
CLINICA NEUROL, 52: 1059|1061, 2012
Symposium 2
The spread pattern and survival in sporadic ALS
Fumiharu Kimura, M.D., Ph.D.
CLINICA NEUROL, 52: 1062|1065, 2012
Symposium 2
Prognosis of amyotrophic lateral sclerosis in relation with pathological pattern of propagation
Shigeo Murayama1) and Yuko Saito2)
CLINICA NEUROL, 52: 1066|1067, 2012
Symposium 2
Dystonia as a common status against a common belief
Takahiro Mezaki, M.D., Ph.D.
CLINICA NEUROL, 52: 1068|1070, 2012
Symposium 2
Hereditary dystonia -Phenotype of DYT1-
Fusako Yokochi, M.D.
CLINICA NEUROL, 52: 1071|1073, 2012
Symposium 2
New medications for dystonia
Yoshimichi Miyazaki, M.D., Kenta Sato, M.D., Hidetaka Koizumi, M.D., Wataru Sako, M.D., Koutaro Asanuma, M.D. and Ryuji Kaji, M.D.
CLINICA NEUROL, 52: 1074|1076, 2012
Symposium 2
Neurosurgical management of dystonias
Takaomi Taira, M.D., Ph.D.
CLINICA NEUROL, 52: 1077|1079, 2012
Symposium 2
Physicians' emotional barriers toward epilepsy surgery
Nobukazu Nakasato, M.D.1), Kazutaka Jin, M.D.1), Masaki Iwasaki, M.D.2), Naoshi Itabashi, M.D.1) and Teiji Tominaga, M.D.2)
CLINICA NEUROL, 52: 1080|1082, 2012
Symposium 2
Epilepsy and associated disorders
Naoki Akamatsu
CLINICA NEUROL, 52: 1083|1083, 2012
Symposium 2
Clinical epileptology and clinical system neuroscience: two sides of the same coin
Riki Matsumoto, M.D., Ph.D.1), Takeharu Kunieda, M.D., Ph.D.2), Ryosuke Takahashi, M.D., Ph.D.1) and Akio Ikeda, M.D., Ph.D.1)
CLINICA NEUROL, 52: 1084|1087, 2012
Symposium 2
Clinical application of newer anti-epileptic drugs
Kiyohito Terada, M.D. and Yushi Inoue, M.D.
CLINICA NEUROL, 52: 1088|1090, 2012
Symposium 2
How to cope with psychiatric illness in patients with epilepsy
Kousuke Kanemoto, M.D., Ph.D., Yukari Tadokoro, M.D., Ph.D. and Tomohiro Oshima, M.D., Ph.D.
CLINICA NEUROL, 52: 1091|1093, 2012
Symposium 2
The indication of DBS in Parkinosn's disease (from a neurosurgical standpoint)
Chikashi Fukaya1), Kazutaka Kobayashi1)2), Hideki Oshima1)2), Takamitsu Yamamoto1) and Yoichi Katayama2)
CLINICA NEUROL, 52: 1095|1097, 2012
Symposium 2
The indication of DBS in Parkinson' disease (from a neurological standpoint)
Hitoshi Yamada, M.D., Ph.D.
CLINICA NEUROL, 52: 1098|1099, 2012
Symposium 2
The role of neurologists in deep brain stimulation for Parkinson disease: a neurosurgical perspective
Atsushi Umemura, M.D.
CLINICA NEUROL, 52: 1100|1102, 2012
Symposium 2
The role of neurologists in DBS treatment on Parkinson's disease
Yasushi Shimo, M.D., Ph.D.
CLINICA NEUROL, 52: 1103|1105, 2012
Symposium 2
Cerebral microbleeds: clinical features and management
Yusuke Yakushiji, M.D. and Hideo Hara, M.D.
CLINICA NEUROL, 52: 1106|1109, 2012
Symposium 2
Medical therapy for intracranial hemorrhage: Update Blood pressure management for prevention and acute treatment
Masatoshi Koga1) and Kazunori Toyoda2)
CLINICA NEUROL, 52: 1110|1112, 2012
Symposium 2
Management of intracranial hemorrhage during anticoagulant therapy with warfarin or novel anticoagulants
Masahiro Yasaka, M.D., Ph.D. and Yasushi Okada, M.D., Ph.D.
CLINICA NEUROL, 52: 1113|1116, 2012
Symposium 2
How to Train Stroke Neurologists
Shinichiro Uchiyama, M.D., Ph.D.
CLINICA NEUROL, 52: 1117|1119, 2012
Symposium 2
Training stroke neurologists`A proposal from a neurosurgeon`
Susumu Miyamoto, M.D., Ph.D.
CLINICA NEUROL, 52: 1120|1122, 2012
Symposium 2
Proposals of undergraduate and postgraduate education to raise stroke-conscious neurologists
Etsuro Mori, M.D.
CLINICA NEUROL, 52: 1123|1125, 2012
Symposium 2
Requisites for the leader of a stroke team
Kazuo Minematsu, M.D., Ph.D.
CLINICA NEUROL, 52: 1126|1127, 2012
Symposium 2
The skill of the stroke physician and the acquirement method
Kazumi Kimura, M.D.
CLINICA NEUROL, 52: 1128|1130, 2012
Symposium 2
How to promote lifetime education of stroke medicine for neurologist
Masayasu Matsumoto, M.D., Ph.D.
CLINICA NEUROL, 52: 1131|1133, 2012
Symposium 2
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Takuya Yagi1), Daisuke Ito1), Yohei Okada2)3), Wado Akamatsu2), Yoshihiro Nihei1), Hideyuki Okano2) and Norihiro Suzuki1)
CLINICA NEUROL, 52: 1134|1136, 2012
Symposium 2
ALS patient-specific iPS cells
Haruhisa Inoue
CLINICA NEUROL, 52: 1137|1138, 2012
Symposium 2
Challenge toward gene-therapy using iPS cells for Duchenne muscular dystrophy
Mitsuo Oshimura, D.Sc., Yasuhiro Kazuki, Ph.D. and Narumi Uno, MS
CLINICA NEUROL, 52: 1139|1142, 2012
Symposium 2
iPS cell transplantation for ischemic brain
Koji Abe, M.D., Toru Yamashita, M.D. and Hiromi Kawai, M.D.
CLINICA NEUROL, 52: 1143|1146, 2012
Symposium 2
Regeneration of the damaged CNS using human iPSCs-derived neural progenitor cells
Hideyuki Okano
CLINICA NEUROL, 52: 1147|1147, 2012
Symposium 2
Anti-SRP myopathy: different entity from myositis
Shigeaki Suzuki, M.D., Ph.D.
CLINICA NEUROL, 52: 1148|1150, 2012
Symposium 2
Myofibrillar myopathies
Satoshi Nakano
CLINICA NEUROL, 52: 1151|1153, 2012
Symposium 2
Recent advances in facioscapulohumeral muscular dystrophy
Yukiko K. Hayashi1)2), Kanako Goto1)2) and Ichizo Nishino1)2)
CLINICA NEUROL, 52: 1154|1157, 2012
Symposium 2
Molecular Targeting Therapy for Fukuyama Muscular Dystrophy
Tatsushi Toda, Mariko Taniguchi-Ikeda and Kazuhiro Kobayashi
CLINICA NEUROL, 52: 1158|1158, 2012
Symposium 2
Congenital myasthenic syndromes
Kinji Ohno, M.D., Ph.D.
CLINICA NEUROL, 52: 1159|1161, 2012
Symposium 2
A pathogenic mechanism of N-terminally pyroglutamylated Aβ and possible application of Alzheimer's disease by inhibition of the pyroglutamylation
Nobuhisa Iwata, Ph.D. and Masashi Asai, Ph.D.
CLINICA NEUROL, 52: 1162|1164, 2012
Symposium 2
Development of Alzheimer's disease treatment based on the molecular mechanism of γ-secretase activity
Taisuke Tomita, M.D.
CLINICA NEUROL, 52: 1165|1167, 2012
Symposium 2
Development of antibodies for immunotherapy of Alzheimer's disease
Shin-ei Matsumoto, Ph.D.1), Haifeng Jin, Ph.D.1), Kazuya Takeda, Ph.D.1), Yukako Hasegawa1), Yumiko Motoi, M.D., Ph.D.1)2), Nobutaka Hattori, M.D., Ph.D.1)2) and Takeshi Tabira, M.D., Ph.D.1)
CLINICA NEUROL, 52: 1168|1170, 2012
Symposium 2
Alzheimer disease and tau protein
Toshihisa Tanaka, Daisuke Mayuyama and Masatoshi Takeda
CLINICA NEUROL, 52: 1171|1173, 2012
Symposium 2
Contribution of brain function analysis to the evolution of neurorehabilitation
Ichiro Miyai1), Masahito Mihara1)2), Noriaki Hattori1), Megumi Hatakenaka1), Teiji Kawano1) and Hajime Yagura1)
CLINICA NEUROL, 52: 1174|1177, 2012
Symposium 2
Development of newer rehabilitative measures for hemiparetic upper limb after stroke
Meigen Liu, M.D.
CLINICA NEUROL, 52: 1178|1181, 2012
Symposium 2
Stimulation of primary motor cortex and reorganization of cortical function
Youichi Saitoh, Koichi Hosomi and Tomoyuki Maruo
CLINICA NEUROL, 52: 1182|1184, 2012
Symposium 2
A new neuroscientific approach using decoded neurofeedback (DecNef)
Kazuhisa Shibata
CLINICA NEUROL, 52: 1185|1187, 2012
Symposium 2
Strategy on dealing with noisy NIRS data: implications on functional neuroimaging on swallowing
Ippeita Dan1), Toshifumi Sano1), Haruka Dan2) and Eiju Watanabe2)
CLINICA NEUROL, 52: 1188|1190, 2012
Symposium 2
Cortical activity in swallowing movement
Masanaga Yamawaki
CLINICA NEUROL, 52: 1191|1191, 2012
Symposium 2
Effects of pharyngeal electrical stimulation on the swallowing reflex and its possible clinical application
Makoto Inoue, D.D.S., Ph.D.
CLINICA NEUROL, 52: 1192|1194, 2012
Symposium 2
Therapeutic approach targeting TRP channels and development of anti-aspiration drugs
Satoru Ebihara
CLINICA NEUROL, 52: 1195|1197, 2012
Symposium 2
Pathophysiology of movement disorders
Atsushi Nambu
CLINICA NEUROL, 52: 1198|1200, 2012
Symposium 2
Pathophysiology of Parkinson's disease from the viewpoint of deep brain stimulation
Hirokazu Iwamuro, M.D., Ph.D.
CLINICA NEUROL, 52: 1201|1203, 2012
Symposium 2
Abnormal plasticity and drug effect in Parkinson's disease
Hiroyuki Enomoto and Yoshikazu Ugawa
CLINICA NEUROL, 52: 1204|1206, 2012
Symposium 3
Anti-androgen therapy for spinal and bulbar muscular atrophy (SBMA)
Masahisa Katsuno, M.D.1), Haruhiko Banno, M.D.1)2), Keisuke Suzuki, M.D.1), Atsushi Hashizume, M.D.1), Hiroaki Adachi, M.D.1), Fumiaki Tanaka, M.D.1)3) and Gen Sobue, M.D.1)
CLINICA NEUROL, 52: 1207|1209, 2012
Symposium 3
Sialic acid supplementation therapy for distal myopathy with rimmed vacuoles (GNE myopathy)
Ichizo Nishino, M.D., Ph.D. and Satoru Noguchi, M.D.
CLINICA NEUROL, 52: 1210|1212, 2012
Symposium 3
Gene therapy with oligonucleotides for neurological diseases
Takanori Yokota, M.D.
CLINICA NEUROL, 52: 1213|1213, 2012
Symposium 3
Clinical translation of hepatocyte growth factor for amyotrophic lateral sclerosis
Hitoshi Warita, M.D., Ph.D., Masaaki Kato, M.D., Ph.D., Naoki Suzuki, M.D., Ph.D., Yasuto Itoyama, M.D., Ph.D. and Masashi Aoki, M.D., Ph.D.
CLINICA NEUROL, 52: 1214|1217, 2012
Symposium 3
Frontotemporal lobar degeneration (FTLD)-changes of its concept and classification based on aggregated proteins
Imaharu Nakano, M.D.
CLINICA NEUROL, 52: 1218|1220, 2012
Symposium 3
Conjoint pathological cascades mediated by RNA-binding proteins, TDP-43, FUS and Ataxin-2
Daisuke Ito, M.D., Ph.D.
CLINICA NEUROL, 52: 1221|1223, 2012
Symposium 3
Aphasia and related impairments pertaining to FTLD
Mika Otsuki, M.D., Ph.D.
CLINICA NEUROL, 52: 1224|1227, 2012
Symposium 3
Selection and optimization of therapy for progressive type multiple sclerosis
Masaaki Niino, M.D., Ph.D.
CLINICA NEUROL, 52: 1229|1230, 2012
Symposium 3
Neuromyelitis optica
Ichiro Nakashima, M.D., Ph.D.
CLINICA NEUROL, 52: 1231|1233, 2012
Symposium 3
Neuro-Behçet disease and neuro-Sweet disease
Kinya Hisanaga
CLINICA NEUROL, 52: 1234|1236, 2012
Symposium 3
Central nervous system involvement of sarcoidosis: diagnosis and management
Toshihide Kumamoto, M.D.
CLINICA NEUROL, 52: 1237|1239, 2012
Symposium 3
Diagnosis and treatments of Hashimoto's encephalopathy
Makoto Yoneda, M.D.
CLINICA NEUROL, 52: 1240|1242, 2012
Symposium 3
Electrodiagnosis in plexopathies; an update
Mana Higashihara, M.D.1) and Masahiro Sonoo, M.D.2)
CLINICA NEUROL, 52: 1243|1245, 2012
Symposium 3
Reference values for concentric needle single fiber EMG
Norito Kokubun, M.D.
CLINICA NEUROL, 52: 1246|1248, 2012
Symposium 3
Non-invasive quantitative EMG: invention of the "Clustering Index (CI)" method
Haruo Uesugi, M.D.1), Masahiro Sonoo, M.D.2)/, Mana Higashihara, M.D.3), Erik Stalberg, M.D.4) and Hisatoshi Saito, M.D.5)
CLINICA NEUROL, 52: 1249|1251, 2012
Symposium 3
The electrophysiologic diagnosis for muscle ion channelopathies
Yumiko Arimura, M.D.1), Tomonori Nakamura, M.D.1), Michiyoshi Yoshimura, M.D.1), Akiko Uehara, M.D.1), Kimiyoshi Arimura, M.D.1)2), Shin-ichi Sakoda, M.D.1) and Hiroshi Takashima, M.D.1)
CLINICA NEUROL, 52: 1252|1255, 2012
Symposium 3
The contributions to clinical neurology of the axonal excitability property measurements
Kazuaki Kanai, M.D.
CLINICA NEUROL, 52: 1256|1258, 2012
Symposium 3
Glucose intolerance in myotonic dystrophy type 1
Hiroto Takada, M.D.1), Yoshinobu Oyama, M.D.1), Seiko Kon, M.D.1) and Takashi Goto, M.D.2)
CLINICA NEUROL, 52: 1259|1260, 2012
Symposium 3
Management of atrioventricular conduction abnormalities in myotonic dystrophy
Takuhisa Tamura
CLINICA NEUROL, 52: 1261|1263, 2012
Symposium 3
Clinical features and care of patients with congenital and childhood-onset myotonic dystrophy
Keiko Ishigaki, M.D., Ph.D.1), Ayako Muto, M.D., Ph.D.2) and Makiko Osawa, M.D., Ph.D.1)
CLINICA NEUROL, 52: 1264|1266, 2012
Symposium 3
Myotonic dystrophy type 2
Takashi Kimura, M.D., Ph.D.
CLINICA NEUROL, 52: 1267|1269, 2012
Symposium 3
Molecular mechanism of botlinum toxin therapy for spasticity
Takashi Sakamoto, M.D.
CLINICA NEUROL, 52: 1270|1271, 2012
Symposium 3
Treatment and indication of botulinum toxin type A for limb spasticity
-Can we break the 6 months barrier?
Ai Miyashiro, M.D.
CLINICA NEUROL, 52: 1272|1274, 2012
Symposium 3
Botulinum toxin treatment and rehabilitation; Motion analysis for reconstruction of movement
Eiichi Saitoh, Hitoshi Kagaya and Hiroki Tanikawa
CLINICA NEUROL, 52: 1275|1275, 2012
Symposium 3
Cardiovascular autonomic function and brain imaging
Masato Asahina, M.D., Ph.D.
CLINICA NEUROL, 52: 1276|1278, 2012
Symposium 3
Anterior prefrontal cortex and serotonergic system activation during Zen meditation practice induces negative mood improvement and increased alpha band in EEG
Hideho Arita, M.D.
CLINICA NEUROL, 52: 1279|1280, 2012
Symposium 3
Brain imaging and gastrointestinal function
Shin Fukudo, MD, PhD
CLINICA NEUROL, 52: 1281|1281, 2012
Symposium 3
Brain imaging and bladder function
Ryuji Sakakibara, M.D.
CLINICA NEUROL, 52: 1282|1285, 2012
Symposium 3
Imaging analysis of central nerve system for sexual arousal and sexual interest
Akira Tsujimura, Hiroshi Kiuchi, Tetsuya Takao, Yasushi Miyagawa and Norio Nonomura
CLINICA NEUROL, 52: 1286|1286, 2012
Symposium 3
The practical use of acupuncture and moxibustion treatment cooperated with neurological practice
Satoru Yamaguchi, Ph.D.1) and Nobuo Araki, M.D., Ph.D.2)
CLINICA NEUROL, 52: 1287|1289, 2012
Symposium 3
Acupuncture for painful diabetic neuropathy
Daichi Kasuya, M.D.
CLINICA NEUROL, 52: 1290|1293, 2012
Symposium 3
Mechanisms of acupuncture and moxibustion on symptoms of neurology
Kazunori Itoh, Shingo Saito, Shunsaku Sahara and Yuki Naitoh
CLINICA NEUROL, 52: 1294|1296, 2012
Symposium 3
Acupuncture; as a valuable tool for headache
Haruki Toriumi, Taeko Ebine, Toshiya Kuroi, Shibata Mamoru, Toshihiko Shimizu and Norihiro Suzuki
CLINICA NEUROL, 52: 1297|1298, 2012
Symposium 3
Application of acupuncture as a headache management tool
Sninya Manaka, M.D.
CLINICA NEUROL, 52: 1299|1302, 2012
Symposium 3
Progress of myasthenia gravis: discovery of Lrp4 antibodies
Masakatsu Motomura, M.D.1) and Osamu Higuchi, Ph.D.2)
CLINICA NEUROL, 52: 1303|1305, 2012
Symposium 3
Anti-MuSK antibodies in myasthenia gravis block binding of collagen Q to MuSK
Kinji Ohno, M.D.
CLINICA NEUROL, 52: 1306|1308, 2012
Symposium 3
The impairment of excitation-contraction (E-C) coupling in myasthenia gravis
Tomihiro Imai, M.D., Ph.D.
CLINICA NEUROL, 52: 1309|1311, 2012
Symposium 3
New clinical entity of myasthenia gravis with autoimmune targets of heart and skeletal muscles
Shigeaki Suzuki, M.D., Ph.D.
CLINICA NEUROL, 52: 1312|1314, 2012
Symposium 3
Muscle fiber atrophy
Ikuya Nonaka, M.D.
CLINICA NEUROL, 52: 1315|1317, 2012
Symposium 3
Spatial orientation under microgravity
Izumi Koizuka
CLINICA NEUROL, 52: 1318|1320, 2012
Symposium 3
Sleep and biological rhythm in space
Kazuo Mishima, M.D., Ph.D.
CLINICA NEUROL, 52: 1321|1324, 2012
Symposium 3
Prion-like protein propagation in neurodegenerative diseases
Masato Hasegawa1), Takashi Nonaka1), Masami Suzukake1), Hiroshi Tsuji1)2), Akira Tamaoka2), Mari Yoshida3), Shigeo Murayama4), Tetsuaki Arai5) and Haruhiko Akiyama6)
CLINICA NEUROL, 52: 1325|1326, 2012
Symposium 3
Molecular mechanism of early-onset familial PD
Shigeto Sato
CLINICA NEUROL, 52: 1327|1328, 2012
Symposium 3
Is "Non-Cell Autonomous" neuron death common to neurodegenerative diseases?
Koji Yamanaka, M.D., Ph.D.
CLINICA NEUROL, 52: 1329|1331, 2012
Symposium 3
Aiming to develop biochemical biomarkers for Parkinson's disease and related disorders
Takahiko Tokuda, M.D.
CLINICA NEUROL, 52: 1332|1334, 2012
Symposium 3
One year after the Great Tohoku Disaster
Masashi Aoki, M.D.
CLINICA NEUROL, 52: 1336|1338, 2012
Symposium 3
One year after the earthquake in Fukushima
Yoshikazu Ugawa, M.D.
CLINICA NEUROL, 52: 1339|1342, 2012
Symposium 3
The Great East Japan Earthquake: One year at a private hospital in Miyagi prefecture
Jinichi Saito
CLINICA NEUROL, 52: 1343|1344, 2012
Symposium 3
The events of the last one year in Fukushima Hamadori
Hareaki Seki, Nobuhito Oda and Takashi Aita
CLINICA NEUROL, 52: 1345|1347, 2012
Symposium 3
Rescue system establishment for neurological patients in case of Natural Disastrous Emergency
Koji Abe, M.D.
CLINICA NEUROL, 52: 1348|1350, 2012
Symposium 3
Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy
Jin Nakahara, M.D., Ph.D.
CLINICA NEUROL, 52: 1351|1353, 2012
Symposium 3
Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease
Katsuhisa Masaki, M.D., Ph.D.
CLINICA NEUROL, 52: 1354|1356, 2012
Symposium 3
Strategies of myelin regeneration with optogenetically controlled glial cells
Makoto Sawada
CLINICA NEUROL, 52: 1357|1359, 2012
Symposium 3
Consideration of the pathogenesis of CARASIL
Hiroaki Nozaki, M.D., Ph.D.
CLINICA NEUROL, 52: 1360|1362, 2012
Symposium 3
Clinical manifestations and neuroradiological findings of CARASIL with a novel mutation
Mamoru Shibata
CLINICA NEUROL, 52: 1363|1364, 2012
Symposium 3
Disturbance in neurovascular unit plays a pivotal role in pathophysiology of small vessel disease in the brain
Yoshiaki Itoh, M.D., Haruki Toriumi, M.D., Taeko Ebine, M.D., Miyuki Unekawa, M.D., Satoshi Yamada, M.D., Fumie Konoeda, M.D., Kenzo Koizumi, M.D., Yutaka Tomita, M.D. and Norihiro Suzuki, M.D.
CLINICA NEUROL, 52: 1365|1368, 2012
Symposium 3
Ataxic form of Hashimoto's encephalopathy
Makoto Yoneda, M.D.
CLINICA NEUROL, 52: 1369|1371, 2012
Symposium 3
The mechanism, diagnosis and treatment of HHV-6B encephalitis
Tetsushi Yoshikawa, M.D., Ph.D.
CLINICA NEUROL, 52: 1372|1374, 2012
Symposium 3
Development of therapeutic interventions for prion disease
Yoshio Tsuboi1) and Katsumi Doh-ura2)
CLINICA NEUROL, 52: 1375|1375, 2012
Symposium 3
Neuroimaging investigation in psychiatry
Toshiaki Onitsuka, M.D., Ph.D.
CLINICA NEUROL, 52: 1376|1378, 2012
Symposium 3
Neuropsychological approach to elucidating delusion and psychotic symptoms
Motoichiro Kato, M.D.
CLINICA NEUROL, 52: 1379|1381, 2012
Symposium 3
Neuropsychological aspects of neurological diseases
Mitsuru Kawamura, M.D.
CLINICA NEUROL, 52: 1382|1382, 2012
Late Breaking Symposium-1
Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): its clinical concept and the review of the previously reported cases
Shu-ichi Ikeda, M.D.
CLINICA NEUROL, 52: 1383|1385, 2012
Late Breaking Symposium-2
Adult-onset hereditary leukoencephalopathy: classification and molecular basis of the disorder
Takeshi Ikeuchi, M.D., Ph.D.
CLINICA NEUROL, 52: 1386|1389, 2012
Late Breaking Symposium-3
Hereditary diffuse leukoencephalopathy with neuroaxonal spheroids (HDLS) in early-onset dementia
Akira Tamaoka, M.D.1), Akihide Mochizuki, M.D.2), Akiko Ishii, M.D.1), Tetsuto Yamaguchi, M.D.1), Megumi Akamatsu, M.D.1) and Hiroshi Takuma, M.D.1)
CLINICA NEUROL, 52: 1390|1392, 2012
Symposium 1
Myotonic dystrophy-from pathomechanism as a RNA disease to future clinical trials
Masanori P. Takahashi, M.D.
CLINICA NEUROL, 52: 1393|1396, 2012